Letter to the House and Senate Appropriations Subcommittees on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies urging the Subcommittee to prioritize the U.S. Food and Drug Administration's (FDA) during Fiscal Year (FY) 2017 by increasing the agency's appropriated funding by $120 million.
Letter to the House and Senate Labor, Health and Human Services, Education, and Related Agencies Appropriations Subcommittees, urging the Subcommitees to prioritize funding for adult immunization related activities at the Department of Health and Human Services (HHS) for FY2017.
Letter to the Office of Science Policy, Engagement, Education, and Communications (OSPEEC) at the National Heart, Lung, and Blood Institute (NHLBI) urging the Institute to include the Afib Optimal Treatment Task Force's critical challenge of developing an effective integrated bleeding risk assessment tool as part of the NHLBI's final Strategic Research Priorities.
Letter from the Alliance for Aging Research applauding the Senate Health, Education, Labor, and Pensions Committee's efforts in addressing the ways in which combination products are reviewed by the U.S. Food and Drug Administration (FDA).
The Alliance for Aging Research signed onto the U.S. Stakeholder Forum for Antibiotic Resistance (S-FAR) sign-on letter for the Senate HELP Committee, supporting S.185, the Promise for Antibiotics and Therapeutics for Health (PATH) Act.
The Alliance for Aging Research signed on to a Coalition for Health Funding letter in support of increasing the Departments of Labor, Health and Human Services, and Education and related agencies appropriations subcommittee, to increase the 302(b) allocations for the agencies under the subcommittee's jurisdiction.
The Alliance for Aging Research wrote a letter to the Centers for Disease Control and Prevention (CDC) requesting modifications to the 2016 CDC Guidelines for Prescribing Opioids for Chronic Pain. Specifically, the Alliance recommended the CDC modify the guidelines by:
Including a statement calling for further investment of federal resources into clinical research to assist providers in tailoring long-term opioid use.
Requiring Department of Health and Human Services (HHS) to provide an updated clinical evidence review of the guidelines
Calling on public and private payers to broadly cover the cost of non-pharmacologic interventions for pain sufferers.
Adding more resources to www.cdc.gov on the safe use of non-opioid pain treatment
Removing the non-evidenced based dosage recommendations
Removing the time/specific pill limit for acute pain treatment
Sign up for our email newsletter, Living Longer & Loving It, for the latest information on scientific research on aging and health.